ChemicalBook > CAS DataBase List > Lenalidomide-d5

Lenalidomide-d5

Product Name
Lenalidomide-d5
CAS No.
1227162-34-6
Chemical Name
Lenalidomide-d5
Synonyms
CC-5013-d5;1-Oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline-d5;3-(4-Amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-2,6-piperidinedione-d5
CBNumber
CB43070473
Molecular Formula
C13H8D5N3O3
Formula Weight
264.29142889
MOL File
1227162-34-6.mol
More
Less

Lenalidomide-d5 Property

storage temp. 
Store at -20°C
solubility 
DMSO: soluble,Methanol: soluble
form 
A solid
color 
White to off-white
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H302Harmful if swallowed

Precautionary statements

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P270Do not eat, drink or smoke when using this product.

P301+P312IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.

P330Rinse mouth.

P501Dispose of contents/container to..…

More
Less

N-Bromosuccinimide Price

Cayman Chemical
Product number
22370
Product name
Lenalidomide-d5
Purity
≥99% deuterated forms (d1-d5)
Packaging
500μg
Price
$201
Updated
2024/03/01
Cayman Chemical
Product number
22370
Product name
Lenalidomide-d5
Purity
≥99% deuterated forms (d1-d5)
Packaging
1mg
Price
$362
Updated
2024/03/01
AK Scientific
Product number
3538DG
Product name
3-(7-Amino-3-oxo-1H-isoindol-2-yl)-3,4,4,5,5-pentadeuteriopiperidine-2,6-dione
Packaging
1mg
Price
$500
Updated
2021/12/16
aablocks
Product number
AA009JKU
Product name
Lenalidomide-d5
Purity
≥99%deuteratedforms(d<sub>1</sub>-<wbr/>d<sub>5</sub>)
Packaging
1mg
Price
$422
Updated
2021/12/16
More
Less

Lenalidomide-d5 Chemical Properties,Usage,Production

Biological Activity

Lenalidomide-d5 is intended for use as an internal standard for the quantification of lenalidomide by GC- or LC-MS. Lenalidomide is related to thalidomide and, at 10 μM, alters gene expression and cell viability in a range of cancer cell lines.1 It also induces proliferation and enhances the functional capacity of T lymphocytes, amplifying co-stimulatory signaling pathways.2 Lenalidomide is effective in hematologic cancers, including lymphomas and myelomas.3,4

References

1.Kim, K., An, S., Cha, H.J., et al.Lenalidomide induces apoptosis and alters gene expression in non-small cell lung cancer cellsOncol.Lett.5(2)588-596(2013) 2.McDaniel, J.M., Pinilla-Ibarz, J., and Epling-Burnette, P.K.Molecular action of lenalidomide in lymphocytes and hematologic malignanciesAdv. Hematol.513702(2012) 3.Latif, T., Chauhan, N., Khan, R., et al.Thalidomide and its analogues in the treatment of multiple myelomaExp.Hermatol.Oncol.1(1)27(2012) 4.Merli, M., Ferrario, A., Basilico, C., et al.Novel agents in indolent lymphomasTher.Adv.Hematol.4(2)133-148(2013)

Lenalidomide-d5 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Lenalidomide-d5 Suppliers

SIMSON PHARMA LIMITED
Tel
+91-8291074273
Email
k.das@simsonpharma.com
Country
India
ProdList
228
Advantage
58